COMPOUNDS / ADAPTOGEN / MILK THISTLE
ADAPTOGEN

MILK THISTLE

LOW RISK
BEST FOR:Liver Support●●●●●●●●○○8/10
MILK THISTLE · SILYBUM MARIANUM · SILYMARIN · SILIBININ · SILYBIN · LEGALON · MILK THISTLE EXTRACT · ST. MARY'S THISTLE
HepatoprotectiveAntioxidantFlavonolignanLiver SupportHerbal Supplement

Hepatoprotective herb whose silymarin extract acts as antioxidant, antifibrotic, and toxin-blockade agent for liver support.

ROUTE / DOSAGE
LOW150mg
STANDARD300-600mg
HIGH800mg+
Note: Standardized to 70-80% silymarin; typically divided 2-3x daily. Phytosome forms have higher bioavailability - reduce dose.
CYCLE
Daily use safe for up to 41 months continuous use in clinical studies
BIOAVAILABILITY
Low oral (~10%) phytosome formulations ~80%
ACTIVE DURATION
8-12 hours (subjective)
STORAGE
Room temperature dry away from light keep sealed
HALF-LIFE
4-8 hours (plasma)
DURATION BREAKDOWN
Total8-12 hours
Onset2-6 hours
Come upN/A (supplement, not psychoactive)
Peak2-4 hours
Offset4-8 hours
After effectsMinimal; hepatoprotective effects accumulate with daily use
Duration varies by route, dose, and individual. Source: community reports.
§ 01 — EFFECTS
6 documented
Hepatoprotective
Antioxidant
Anti-inflammatory
Antifibrotic
Immunomodulatory
Chemopreventive
§ 02 — RISKS
Mild gastrointestinal distress (nausea, diarrhea) most common
Rare allergic reactions in individuals sensitive to Asteraceae family plants
Caution advised during pregnancy despite limited safety data
Potential interactions with narrow therapeutic window drugs
May affect phase II metabolism of certain pharmaceuticals
§ 03 — INTERACTIONS
Interaction data not yet available for this compound.
§ 04 — SCIENCE

Milk thistle is the most well-researched plant for liver disease treatment, with a 2,000-year history of medicinal use. Preclinical studies demonstrate hepatoprotection against acetaminophen, carbon tetrachloride, alcohol, and Amanita phalloides toxicity. Clinical evidence for alcoholic liver disease, viral hepatitis, and drug-induced liver injury is encouraging but heterogeneous, and well-designed randomized trials remain needed. Anticancer, anti-Alzheimer, and anti-Parkinson effects have been shown in vitro and in animal models but lack robust human clinical data. Safety profile is excellent: well tolerated at doses up to 700 mg three times daily for 24 weeks, with minimal drug interactions and no major cytochrome P450 effects.

§ 06 — SOURCES
[1]
PubMed PMID 20564545
pubmed.ncbi.nlm.nih.gov ↗
[2]
PubMed PMID 30080294
pubmed.ncbi.nlm.nih.gov ↗
[3]
PubMed PMID 16225032
pubmed.ncbi.nlm.nih.gov ↗
[4]
PubMed PMID 31069872
pubmed.ncbi.nlm.nih.gov ↗
[5]
PubMed PMID 40329723
pubmed.ncbi.nlm.nih.gov ↗
[6]
PubMed PMID 34968721
pubmed.ncbi.nlm.nih.gov ↗
[7]
PubMed PMID 36302565
pubmed.ncbi.nlm.nih.gov ↗
[8]
PubMed PMID 34399200
pubmed.ncbi.nlm.nih.gov ↗
Disclaimer. Protokol.wiki is an informational reference. Nothing on this site is medical advice. Compounds listed may be unapproved, unregulated, or illegal in your jurisdiction. Consult a licensed physician before use. Data compiled from peer-reviewed literature.
METHODOLOGYCONTRIBUTECONTACT